Major comorbid conditions in asthma and association with asthma-related hospitalizations and emergency department admissions in adults: Results from the German national health telephone interview survey (GEDA) 2010

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Steppuhn, Henriette ^a,b   Langen, Ute ^a   Scheidt Nave, Christa ^a   Keil, Thomas ^b,c  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Acetylsalicylic acid exacerbated respiratory disease; Adult; Allergic rhinitis; Aspirin induced asthma; Asthma; Gastroesophageal reflux; Gastroesophageal reflux disease; Hospitalization; National health survey

Indexed keywords

ACETYLSALICYLIC ACID EXACERBATED RESPIRATORY DISEASE; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BODY MASS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HOSPITAL CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; RESPIRATORY TRACT DISEASE; SELF REPORT; SMOKING; TELECONSULTATION; ADOLESCENT; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; EMERGENCY HEALTH SERVICE; GERMANY; HOSPITAL ADMISSION; INTERVIEW; LUNG DISEASES; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; RHINITIS, ALLERGIC; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ACETYLSALICYLIC ACID;

ADOLESCENT; ADULT; AGED; ASPIRIN; ASTHMA; COMORBIDITY; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; GASTROESOPHAGEAL REFLUX; GERMANY; HEALTH SURVEYS; HOSPITALIZATION; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; LUNG DISEASES; MALE; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC; YOUNG ADULT;

EID: 84880005475     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-46     Document Type: Article

References (50)

1. Hommers L, Ellert U, Scheidt-Nave C, Langen U. Factors contributing to conductance and outcome of specific immunotherapy: data from the German National Health Interview and Examination Survey 1998. Eur J Public Health 2007, 17:278-284. 10.1093/eurpub/ckl241, 17060335.
2. Braman SS. The global burden of asthma. Chest 2006, 130(Suppl 1):4S-12S.
3. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med 2009, 9:24. 10.1186/1471-2466-9-24, 2698859, 19454036.
4. Boulet LP, Boulay ME. Asthma-related comorbidities. Expert Rev Respir Med 2011, 5:377-393. 10.1586/ers.11.34, 21702660.
5. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009, 33:897-906. 10.1183/09031936.00121308, 19336592.
6. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention 2011, http://ginasthma.org/, Global Initiative for Asthma (GINA).
7. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, Van Weel C, Agache I, Ait-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, Van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008, 63(Suppl 86):8-160.
8. Price D. Asthma and allergic rhinitis: Linked in treatment and outcomes. Ann Thorac Med 2010, 5:63-64. 10.4103/1817-1737.62467, 2883199, 20582169.
9. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, Wjst M, Cerveri I, Pin I, Bousquet J, Jarvis D, Burney PG, Neukirch F, Leynaert B. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008, 372:1049-1057. 10.1016/S0140-6736(08)61446-4, 18805333.
10. Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med 2006, 6(Suppl 1):4. 10.1186/1471-2466-6-S1-S4, 1386704, 16483363.
11. Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, Bjermer L. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected]. Clin Exp Allergy 2005, 35:723-727. 10.1111/j.1365-2222.2005.02251.x, 15969661.
12. Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005, 35:282-287. 10.1111/j.1365-2222.2005.02182.x, 15784104.
13. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Nationale VersorgungsLeitlinie Asthma - Langfassung, 2. Auflage. Version 1.3 2011, http://www.versorgungsleitlinien.de/themen/asthma, Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF).
14. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, Van Wijk RG, Ohta K, Zuberbier T, Schunemann HJ. Global Allergy Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010, 126:466-476. 10.1016/j.jaci.2010.06.047, 20816182.
15. Cazzola M, Calzetta L, Bettoncelli G, Novelli L, Cricelli C, Rogliani P. Asthma and comorbid medical illness. Eur Respir J 2011, 38:42-49. 10.1183/09031936.00140310, 21177843.
16. Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007, 56:1654-1664. 10.1136/gut.2007.122465, 2095717, 17682001.
17. McCallister JW, Parsons JP, Mastronarde JG. The relationship between gastroesophageal reflux and asthma: an update. Ther Adv Respir Dis 2011, 5:143-150. 10.1177/1753465810384606, 20926507.
18. Kiljander TO, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2010, 181:1042-1048. 10.1164/rccm.200910-1537OC, 20110554.
19. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy, Asthma & Immunology Research 2011, 3:3-10. 10.4168/aair.2011.3.1.3, 23862756.
20. Palikhe NS, Kim JH, Park HS. Update on recent advances in the management of aspirin exacerbated respiratory disease. Yonsei Med J 2009, 50:744-750. 10.3349/ymj.2009.50.6.744, 2796398, 20046412.
21. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006, 118:773-786. 10.1016/j.jaci.2006.07.024, 17030227.
22. Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2005, 116:970-975. 10.1016/j.jaci.2005.08.035, 16275362.
23. Bavbek S, Celik G, Demirel YS, Misirligil Z. Risk factors associated with hospitalizations for asthma attacks in Turkey. Allergy Asthma Proc 2003, 24:437-442.
24. Bavbek S, Yilmaz I, Celik G, Aydin O, Erkekol FO, Orman A, Kurt E, Ediger D, Dursun B, Abadoglu O, Ozseker F, Akkaya E, Karakis GP, Canbakan S, Yuksel S, Misirligil Z. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey. Allergol Immunopathol 2012, 40:225-230.
25. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004, 328:434. 10.1136/bmj.328.7437.434, 344260, 14976098.
26. Gaugris S, Sazonov-Kocevar V, Thomas M. Burden of concomitant allergic rhinitis in adults with asthma. J Asthma 2006, 43:1-7. 10.1080/02770900500446823, 16448958.
27. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, De Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE, American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009, 180:59-99. 10.1164/rccm.200801-060ST, 19535666, American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations.
28. Kurth BM, Lange C, Kamtsiuris P, Holling H. Health monitoring at the Robert Koch Institute. Status and perspectives. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009, 52:557-570. 10.1007/s00103-009-0843-3, 19343279.
29. Gabler S, Haeder S. Idiosyncrasies in Telephone Sampling - The Case of Germany. International Journal of Public Opinion Research 2002, 14:339-345.
30. Salmon CT, Nichols JS. The Next-Birthday Method of Respondent Selection. Public Opin Q 1983, 47:270-276.
31. Robert Koch-Institut Daten und Fakten: Ergebnisse der Studie " Gesundheit in Deutschland aktuell 2010" Beiträge zur Gesundheitsberichterstattung des Bundes 2012, Berlin: RKI, Robert Koch-Institut.
32. Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System http://www.cdc.gov/brfss/, Centers for Disease Control and Prevention (CDC).
33. World Health Organisation Obesity and Overweight. Fact Sheet N.311 http://www.who.int/mediacentre/factsheets/fs311/en/, World Health Organisation.
34. Schroedter JH, Lechert Y, Lüttinger P. Die Umsetzung der Bildungsskala ISCED-1997 für die Volkszählung 1970, die Mikrozensus- Zusatzerhebung 1971 und die Mikrozensen 1976-2004. ZUMA-Methodenbericht. 2006/08 2006, Mannheim: ZUMA.
35. Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 2007, 9:53-56. 10.1080/14622200601078293, 17365736.
36. Scheidt-Nave C, Kamtsiuris P, Gosswald A, Holling H, Lange M, Busch MA, Dahm S, Dolle R, Ellert U, Fuchs J, Hapke U, Heidemann C, Knopf H, Laussmann D, Mensink GB, Neuhauser H, Richter A, Sass AC, Rosario AS, Stolzenberg H, Thamm M, Kurth BM. German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave. BMC Publ Health 2012, 12:730.
37. Du Y, Heidemann C, Gosswald A, Schmich P, Scheidt-Nave C. Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey 'German Health Update (GEDA)' 2009. BMC Publ Health 2013, 13:166.
38. Lehtonen R, Pakinen E. Practical Method for Design and Analyses of Complex Surveys 2004, Chichester: John Wiley and Sons, 2.
39. Hermann-Kunz E. Allergic diseases in Germany. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2000, 43:400-406.
40. Kasper L, Sladek K, Bochenek G, Duplaga M, Szczeklik A. The frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire. Pneumonol Alergol Pol 2009, 77:431-439.
41. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722. 10.1093/ije/28.4.717, 10480701.
42. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002, 57:569-574. 10.1136/thorax.57.7.569, 1746373, 12096197.
43. Sims EJ, Price D, Haughney J, Ryan D, Thomas M. Current control and future risk in asthma management. Allergy, Asthma & Immunology Research 2011, 3:217-225. 10.4168/aair.2011.3.4.217, 23862756.
44. Hutter N, Knecht A, Baumeister H. Health care costs in persons with asthma and comorbid mental disorders: a systematic review. Gen Hosp Psychiatry 2011, 33:443-453. 10.1016/j.genhosppsych.2011.06.013, 21831446.
45. Littner MR, Leung FW, Ballard ED, Huang B, Samra NK, Lansoprazole Asthma Study Group Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005, 128:1128-1135. 10.1378/chest.128.3.1128, 16162697, Lansoprazole Asthma Study Group.
46. Peters S. The impact of comorbid atopic disease on asthma: clinical expression and treatment. J Asthma 2007, 44:149-161. 10.1080/02770900600925478, 17454331.
47. Kanani AS, Broder I, Greene JM, Tarlo SM. Correlation between nasal symptoms and asthma severity in patients with atopic and nonatopic asthma. Ann Allergy Asthma Immunol 2005, 94:341-347. 10.1016/S1081-1206(10)60985-4, 15801244.
48. Ring J. Weißbuch Allergie in Deutschland 2000 2004, München: Urban &Vogel Verlag, 2.
49. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organisation Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108(5):147-334. Aria Workshop Group; World Health Organisation.
50. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy 2001, 56:377-384. 10.1034/j.1398-9995.2001.056005377.x, 11350300.